









Mercado
/
Acciones
/
nasdaq-ccel
/

Cryo-Cell International Inc

CCEL

4.383USD

+0.045+1.04%

Cierre 11/05, 16:00（ET）Cotizaciones retrasadas 15 min

35.30MCap. mercado

PérdidaP/E TTM



Cryo-Cell International Inc

4.383

+0.045+1.04%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Cryo-Cell International Inc Compañía

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

Información de Cryo-Cell International Inc



Símbolo de cotizaciónCCEL

Nombre de la empresaCryo-Cell International Inc

Fecha de salida a bolsaApr 04, 1994

Director ejecutivoMr. Mark L. Portnoy

Número de empleados82

Tipo de seguridadOrdinary Share

Fin del año fiscalApr 04

Dirección700 Brooker Creek Blvd

CiudadOLDSMAR

Bolsa de valoresNYSE American Consolidated

PaísUnited States of America

Código postal34677

Teléfono18137492104

Sitio Webhttps://www.cryo-cell.com/

Símbolo de cotizaciónCCEL

Fecha de salida a bolsaApr 04, 1994

Director ejecutivoMr. Mark L. Portnoy

Ejecutivos de Cryo-Cell International Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.68M

+6.81%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

Mr. Harold D. Berger, CPA

Independent Director

57.90K

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

Mr. Daniel Mizrahi

Independent Director

30.63K

Ms. Irene Smith

Executive Assistant / Office Manager

Mr. Mark L. Portnoy

Co-Chief Executive Officer, Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. David I. Portnoy

Chairman of the Board, Co-Chief Executive Officer

1.68M

+6.81%

Mr. Oleg Mikulinsky

Chief Information Officer

104.35K

Mr. Harold D. Berger, CPA

Independent Director

57.90K

Ms. Jill M. Taymans

Chief Financial Officer, Vice President - Finance

45.40K

Mr. Daniel Mizrahi

Independent Director

30.63K

Ms. Irene Smith

Executive Assistant / Office Manager

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Processing and storage fees

7.87M

99.28%

Public banking revenue

42.69K

0.54%

Product revenue

14.44K

0.18%

Estadísticas de accionistas

Actualizado: hace 7 horas

Accionistas

Tipos de accionistas

Accionistas

Proporción

Portnoy (David I)

20.83%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

Otro

54.09%

Accionistas

Proporción

Portnoy (David I)

20.83%

Portnoy (Mark)

11.62%

Fleishman (Adam)

6.32%

Hamilton Lane Advisors, LLC

5.09%

SFI Advisors LLC

2.05%

Otro

54.09%

Tipos de accionistas

Accionistas

Proporción

Individual Investor

41.73%

Investment Advisor

5.87%

Private Equity

5.09%

Hedge Fund

0.74%

Investment Advisor/Hedge Fund

0.65%

Research Firm

0.02%

Otro

45.90%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

994.95K

12.35%

-52.37K

2025Q2

4.28M

53.09%

-6.66K

2025Q1

4.88M

60.37%

-1.40K

2024Q4

4.88M

60.35%

-45.33K

2024Q3

4.73M

58.53%

-190.45K

2024Q2

4.72M

57.24%

-175.49K

2024Q1

4.70M

56.72%

-231.88K

2023Q4

4.69M

56.61%

-257.13K

2023Q3

4.69M

56.58%

-265.51K

2023Q2

4.80M

57.00%

-223.23K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Portnoy (David I)

1.68M

20.81%

+107.02K

+6.81%

Sep 18, 2025

Portnoy (Mark)

935.77K

11.61%

Sep 15, 2025

Fleishman (Adam)

509.00K

6.31%

Sep 15, 2025

Hamilton Lane Advisors, LLC

409.73K

5.08%

Sep 30, 2025

SFI Advisors LLC

165.30K

2.05%

Jun 30, 2025

The Vanguard Group, Inc.

129.81K

1.61%

+11.58K

+9.79%

Jun 30, 2025

The MassMutual Trust Company, FSB

111.03K

1.38%

Jun 30, 2025

Mikulinsky (Oleg)

104.35K

1.29%

Sep 15, 2025

Berger (Harold D)

57.90K

0.72%

Sep 15, 2025

Geode Capital Management, L.L.C.

45.83K

0.57%

+601.00

+1.33%

Jun 30, 2025

ETFs relacionados



Actualizado: dom., 2 de nov

Nombre

Proporción

iShares Micro-Cap ETF

Proporción0%

Dividendos



Un total de 9.69M USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Jan 29, 2025

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Feb 28, 2025

Feb 14, 2025

Oct 31, 2024

CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

